Thyroid cancer-associated syndromes, including multiple endocrine neoplasia type 2, were significantly more prevalent than current estimates.

Aug. 23, 2024 — Obesity-related cancer rates in China were ... high response rates in patients with RET gene fusions, regardless of tumor ... Thyroid Problems Linked to Increased Risk of Dementi ...

The US regulator says Retevmo (selpercatinib, formerly LOXO-292) can be used to treat lung and thyroid cancers with a mutation or fusion in the RET gene, specifically non-small cell lung cancer ...

Gavreto (pralsetinib) has since picked up an additional accelerated approval in RET-positive thyroid cancer, although, that was withdrawn after a confirmatory trial failed to show a benefit.

It is also developing GAVRETO for the treatment of RET fusion-positive non-small cell lung cancer, altered thyroid carcinoma, and medullary thyroid carcinoma; BLU-945 for the treatment of ...

Professor Oliver Bathe urges us to rethink papillary thyroid cancer, noting that “low risk” isn’t always synonymous with low ...

TikTok's Fave Weight Loss Drugs: Link to Thyroid Cancer? Demand for Ozempic continues to surge, fueled by social media; but research suggests that for some, use of these injectables may be linked ...

Exelixis delivers a strong Q1 performance with raised 2025 guidance, robust Cabometyx sales, and share buybacks. Read the ...

Autoimmune thyroid disease (AITD) causes cellular damage and alters thyroid gland function by humoral and cell-mediated mechanisms. Cellular damage occurs when sensitized T-lymphocytes and/or ...